Skip to main content
. 2022 Jul 27;14(15):3079. doi: 10.3390/nu14153079

Table 8.

Polymorphisms prevalence with regard to metalloestrogen levels.

Studied Population (n) Cu p-Value Studied Population (n) Zn p-Value Studied Population (n) Fe p-Value Studied Population (n) Co p-Value Studied Population (n) Cd p-Value
OR 95%CI OR 95%CI OR 95%CI OR 95%CI OR 95 %CI
71 - - - 71 - - - 71 - - - 32 - - - 65 - - -
31 1.11 1.04–1.12 0.535 31 0.98 0.84–1.04 0.282 31 1.29 1.19–1.35 0.518 12 1.15 0.361 30 1.21 1.15–1.29 0.023
4 1.09 1.02–1.11 0.037 4 0.87 0.85–0.92 0.553 4 1.34 1.30–1.41 0.722 2 1.27 1.17–1.30 0.114 4 1.20 1.19–1.24 0.091
51 - - - 51 - - 51 - - - 17 - - - 46 - - -
47 1.19 1.17–1.20 0.312 47 0.79 0.76–0.86 0.222 47 1.25 1.21–1.30 0.157 24 1.23 1.20–1.31 0.154 45 1.09 1.04–1.11 0.423
8 1.15 1.11–1.16 0.484 8 0.94 0.92–0.99 0.227 8 1.29 1.22–1.35 0.327 5 1.19 1.16–1.28 0.127 8 1.05 1.01–1.13 0.032
Studied Population (n) Sr p-Value Studied Population (n) Cr p-Value Studied Population (n) Mg p-Value Studied Population (n) Mn p-Value Studied Population (n) Ni p-Value
OR 95%CI OR 95%CI OR 95%CI OR 95%CI OR 95%CI
63 - - - 27 - - - 71 - - - 55 - - - 36 - - -
29 0.89 0.82–0.90 0.400 11 0.76 0.74–0.88 0.355 31 1.24 1.19–1.28 0.518 23 0.86 0.84–1.02 0.058 20 1.07 1.05–1.18 0.040
4 0.77 0.74–0.81 0.237 1 - - - 4 1.11 1.09–1.21 0.722 2 - - - 2 - - -
47 - - - 17 - - - 51 - - - 37 0.97 0.93–0.99 0.087 34 - - -
43 0.91 0.89–0.94 0.196 22 1.01 0.97–1.08 0.624 47 1.15 1.12–1.20 0.145 36 0.90 0.87–0.97 0.869 21 1.10 1.08–1.21 0.827
6 0.83 0.80–0.86 0.274 0 - - - 8 1.27 1.22–1.28 0.058 7 0.86 0.85–0.93 0.680 3 1.16 1.15–1.19 0.564
HHS Vulnerability Disclosure